COVID-19大流行前后美国成年人高血压患病率、意识和控制

IF 2.5 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE
Mohammed Essa, Devesh Malik, Yuan Lu, Huanhuan Yang, Erica S. Spatz, Harlan M. Krumholz, Kamil F. Faridi
{"title":"COVID-19大流行前后美国成年人高血压患病率、意识和控制","authors":"Mohammed Essa,&nbsp;Devesh Malik,&nbsp;Yuan Lu,&nbsp;Huanhuan Yang,&nbsp;Erica S. Spatz,&nbsp;Harlan M. Krumholz,&nbsp;Kamil F. Faridi","doi":"10.1111/jch.70093","DOIUrl":null,"url":null,"abstract":"<p>Hypertension is a leading cause of death and disability in the United States, but national trends in hypertension after the COVID-19 pandemic remain unknown. We analyzed NHANES data from pre-pandemic (2017–March 2020) and post-pandemic (August 2021–August 2023) surveys to determine nationwide prevalence, awareness, and control of hypertension. Weighted, age-standardized prevalence estimates were compared using Poisson regression with prevalence ratios (PRs). Among 14 449 participants representing 237 million US adults, hypertension prevalence was 49.5% pre-pandemic versus 47.7% post-pandemic (PR 0.96; <i>p</i> = 0.15). Overall, hypertension awareness was unchanged (57.7% vs. 53.7%; PR 0.96; <i>p</i> = 0.14) but declined among adults aged 18–39 years (PR 0.78; <i>p</i> = 0.02). Blood pressure control remained low (25.9% vs. 22.3%; PR 0.91; <i>p</i> = 0.06) and worsened in men (PR 0.83; <i>p</i> = 0.01). In conclusion, hypertension prevalence, awareness, and control did not significantly improve post-pandemic. More aggressive public health efforts are needed to reduce the adverse impacts of hypertension in the United States.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":"27 7","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.70093","citationCount":"0","resultStr":"{\"title\":\"Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID-19 Pandemic\",\"authors\":\"Mohammed Essa,&nbsp;Devesh Malik,&nbsp;Yuan Lu,&nbsp;Huanhuan Yang,&nbsp;Erica S. Spatz,&nbsp;Harlan M. Krumholz,&nbsp;Kamil F. Faridi\",\"doi\":\"10.1111/jch.70093\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Hypertension is a leading cause of death and disability in the United States, but national trends in hypertension after the COVID-19 pandemic remain unknown. We analyzed NHANES data from pre-pandemic (2017–March 2020) and post-pandemic (August 2021–August 2023) surveys to determine nationwide prevalence, awareness, and control of hypertension. Weighted, age-standardized prevalence estimates were compared using Poisson regression with prevalence ratios (PRs). Among 14 449 participants representing 237 million US adults, hypertension prevalence was 49.5% pre-pandemic versus 47.7% post-pandemic (PR 0.96; <i>p</i> = 0.15). Overall, hypertension awareness was unchanged (57.7% vs. 53.7%; PR 0.96; <i>p</i> = 0.14) but declined among adults aged 18–39 years (PR 0.78; <i>p</i> = 0.02). Blood pressure control remained low (25.9% vs. 22.3%; PR 0.91; <i>p</i> = 0.06) and worsened in men (PR 0.83; <i>p</i> = 0.01). In conclusion, hypertension prevalence, awareness, and control did not significantly improve post-pandemic. More aggressive public health efforts are needed to reduce the adverse impacts of hypertension in the United States.</p>\",\"PeriodicalId\":50237,\"journal\":{\"name\":\"Journal of Clinical Hypertension\",\"volume\":\"27 7\",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.70093\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jch.70093\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.70093","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

在美国,高血压是导致死亡和残疾的主要原因,但2019冠状病毒病大流行后,全国高血压趋势尚不清楚。我们分析了大流行前(2017 - 2020年3月)和大流行后(2021年8月- 2023年8月)调查的NHANES数据,以确定全国范围内高血压的患病率、意识和控制。加权、年龄标准化的患病率估计值使用泊松回归与患病率比(pr)进行比较。在代表2.37亿美国成年人的14449名参与者中,高血压患病率在大流行前为49.5%,在大流行后为47.7% (PR = 0.96;p = 0.15)。总体而言,高血压意识没有变化(57.7% vs. 53.7%;公关0.96;p = 0.14),但在18-39岁的成年人中有所下降(PR = 0.78;p = 0.02)。血压控制仍然很低(25.9% vs. 22.3%;公关0.91;p = 0.06),男性加重(PR 0.83;p = 0.01)。总之,大流行后高血压的患病率、意识和控制没有显著改善。在美国,需要更积极的公共卫生努力来减少高血压的不利影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID-19 Pandemic

Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID-19 Pandemic

Hypertension is a leading cause of death and disability in the United States, but national trends in hypertension after the COVID-19 pandemic remain unknown. We analyzed NHANES data from pre-pandemic (2017–March 2020) and post-pandemic (August 2021–August 2023) surveys to determine nationwide prevalence, awareness, and control of hypertension. Weighted, age-standardized prevalence estimates were compared using Poisson regression with prevalence ratios (PRs). Among 14 449 participants representing 237 million US adults, hypertension prevalence was 49.5% pre-pandemic versus 47.7% post-pandemic (PR 0.96; p = 0.15). Overall, hypertension awareness was unchanged (57.7% vs. 53.7%; PR 0.96; p = 0.14) but declined among adults aged 18–39 years (PR 0.78; p = 0.02). Blood pressure control remained low (25.9% vs. 22.3%; PR 0.91; p = 0.06) and worsened in men (PR 0.83; p = 0.01). In conclusion, hypertension prevalence, awareness, and control did not significantly improve post-pandemic. More aggressive public health efforts are needed to reduce the adverse impacts of hypertension in the United States.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Hypertension
Journal of Clinical Hypertension PERIPHERAL VASCULAR DISEASE-
CiteScore
5.80
自引率
7.10%
发文量
191
审稿时长
4-8 weeks
期刊介绍: The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信